Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection

Table 5

Analysis patients with vitamin D < 20 ng/mL at baseline.

	Objective; VitD > 20 ng/mL; Yes: 156 (83.9); (%)		Objective: PTH < 65 pg/mL
VitD supplements
Yes	128 (95.5)	0.0001	90 (67.2)	0.43
No	28 (53.8)		39 (73.1)
TDF exposure
Yes	80 (89.9)	0.03	54 (60.7)	0.02
No	76 (78.4)		74 (76.3)
NNRTI exposure
Yes	75 (85.5)	0.58	61 (73.5)	0.22
No	76 (82.5)		67 (65)
PIs exposure
Yes	83 (84.7)	0.75	61 (62.2)	0.04
No	73 (83)		67 (76.1)